Biotech issuance in the U.S. remains active into November, with healthcare companies continuing to draw investor interest despite uneven broader market conditions. Swiss drug developer Windward Bio Group AG is now seeking up to $185.3 million in a Nasdaq listing that would value the company at as much as $1 billion.
Highlights
- Windward Bio plans to raise approximately $185 million by selling 10.3 million shares at $16–$18 each in its U.S. IPO, targeting a valuation up to $1 billion.
- Sanofi agreed to invest $50 million via share and pre-funded warrant purchases, following $310 million in previous Windward equity funding from Novo Holdings, OrbiMed, Blue Owl, and RTW Investments.
- Windward Bio's Nasdaq listing under 'WWB' joins continued biotech IPO activity, reflecting defensive sector interest amid market volatility and high borrowing costs.
Offering terms and backer support
As reported by Reuters, Basel-based Windward said on Monday it plans to sell about 10.3 million shares at $16 to $18 each in its U.S. initial public offering. At the top of that range, the transaction would give the company a valuation of up to $1 billion.Windward has previously raised $310 million in equity financing from Novo Holdings and other healthcare investors including OrbiMed, Blue Owl and RTW Investments. French drugmaker Sanofi has also agreed to buy $50 million of shares and pre-funded warrants in a private placement.
Jefferies, TD Cowen, Piper Sandler and UBS Investment Bank are underwriting the offering. Windward Bio plans to list on the Nasdaq under the symbol "WWB".
Biotech IPO market extends momentum
The deal comes as the healthcare sector continues to underpin the fall IPO window, benefiting from its reputation as a defensive industry while choppy market conditions and higher borrowing costs weigh on issuance in other sectors.Windward is developing antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease and atopic dermatitis. Another drug developer, Rezera, began its U.S. IPO roadshow last week and is expected to go public in New York this week, underscoring continued activity in the biotech listing market.
In our earlier article on the Nasdaq-100 (NDX) and the launch of the JQQQ blockchain-native fund, we noted that the index was under short- and medium-term selling pressure despite holding above its long-term trend. The piece highlighted key technical levels and a range-bound outlook, while arguing that new access routes like JQQQ could support longer-term institutional demand even as near-term downside risks remained elevated.
Latest Healthcare Industry News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
